Vetoquinol Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Vetoquinol wird ein jährliches Gewinn- und Umsatzwachstum von 8.9% bzw. 3.8% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 10.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.2% betragen.
Wichtige Informationen
8.9%
Wachstumsrate der Gewinne
10.3%
EPS-Wachstumsrate
Pharmaceuticals Gewinnwachstum | 17.1% |
Wachstumsrate der Einnahmen | 3.8% |
Zukünftige Eigenkapitalrendite | 9.2% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 05 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
What Vetoquinol SA's (EPA:VETO) P/E Is Not Telling You
Nov 21Subdued Growth No Barrier To Vetoquinol SA's (EPA:VETO) Price
Aug 06Vetoquinol (EPA:VETO) Ticks All The Boxes When It Comes To Earnings Growth
Jul 13An Intrinsic Calculation For Vetoquinol SA (EPA:VETO) Suggests It's 40% Undervalued
Jun 15Why We're Not Concerned About Vetoquinol SA's (EPA:VETO) Share Price
May 01Here's What Analysts Are Forecasting For Vetoquinol SA (EPA:VETO) After Its Annual Results
Mar 24With EPS Growth And More, Vetoquinol (EPA:VETO) Makes An Interesting Case
Jan 13Vetoquinol SA (EPA:VETO) Shares Could Be 32% Below Their Intrinsic Value Estimate
Dec 19Vetoquinol (EPA:VETO) Seems To Use Debt Quite Sensibly
Nov 23Here's Why We Think Vetoquinol (EPA:VETO) Is Well Worth Watching
Oct 06Is Vetoquinol SA (EPA:VETO) Trading At A 45% Discount?
Sep 12Are Investors Undervaluing Vetoquinol SA (EPA:VETO) By 28%?
May 24Is Vetoquinol (EPA:VETO) Using Too Much Debt?
May 03Vetoquinol SA (EPA:VETO) Shares Could Be 22% Below Their Intrinsic Value Estimate
Jan 05Here's Why Vetoquinol (EPA:VETO) Has Caught The Eye Of Investors
Dec 01We Think Vetoquinol (EPA:VETO) Can Stay On Top Of Its Debt
Oct 07Vetoquinol SA (EPA:VETO) Shares Could Be 31% Below Their Intrinsic Value Estimate
Aug 19Do Vetoquinol's (EPA:VETO) Earnings Warrant Your Attention?
Jul 16Vetoquinol SA (EPA:VETO) Shares Could Be 29% Below Their Intrinsic Value Estimate
May 07I Ran A Stock Scan For Earnings Growth And Vetoquinol (EPA:VETO) Passed With Ease
Apr 06Calculating The Intrinsic Value Of Vetoquinol SA (EPA:VETO)
Dec 21Is Vetoquinol (EPA:VETO) Using Too Much Debt?
Nov 29Estimating The Intrinsic Value Of Vetoquinol SA (EPA:VETO)
Sep 10Is Vetoquinol (EPA:VETO) A Risky Investment?
Aug 01Is Vetoquinol SA (EPA:VETO) Trading At A 35% Discount?
May 12Vetoquinol SA's (EPA:VETO) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Feb 11A Look At The Intrinsic Value Of Vetoquinol SA (EPA:VETO)
Jan 20Vetoquinol (EPA:VETO) Shareholders Have Enjoyed An Impressive 111% Share Price Gain
Dec 29How Much Is Vetoquinol SA (EPA:VETO) Paying Its CEO?
Dec 09We Think Vetoquinol's (EPA:VETO) Statutory Profit Might Understate Its Earnings Potential
Nov 18Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 588 | 60 | 67 | 87 | 5 |
12/31/2025 | 561 | 56 | 61 | 80 | 6 |
12/31/2024 | 538 | 53 | 61 | 78 | 6 |
6/30/2024 | 537 | 47 | 70 | 86 | N/A |
3/31/2024 | 533 | 51 | 70 | 88 | N/A |
12/31/2023 | 529 | 56 | 70 | 89 | N/A |
9/30/2023 | 527 | 57 | 76 | 98 | N/A |
6/30/2023 | 525 | 59 | 83 | 106 | N/A |
3/31/2023 | 533 | 53 | 61 | 84 | N/A |
12/31/2022 | 540 | 48 | 40 | 63 | N/A |
9/30/2022 | 538 | 48 | 29 | 54 | N/A |
6/30/2022 | 537 | 48 | 17 | 46 | N/A |
3/31/2022 | 529 | 55 | 37 | 68 | N/A |
12/31/2021 | 521 | 63 | 57 | 90 | N/A |
9/30/2021 | 504 | 52 | -1 | 91 | N/A |
6/30/2021 | 487 | 40 | -59 | 93 | N/A |
3/31/2021 | 457 | 30 | -56 | 93 | N/A |
12/31/2020 | 427 | 19 | -53 | 92 | N/A |
9/30/2020 | 418 | 25 | 5 | 85 | N/A |
6/30/2020 | 408 | 31 | 64 | 78 | N/A |
3/31/2020 | 402 | 30 | 51 | 65 | N/A |
12/31/2019 | 396 | 29 | 38 | 52 | N/A |
9/30/2019 | 385 | 31 | 28 | 43 | N/A |
6/30/2019 | 374 | 33 | 19 | 35 | N/A |
3/31/2019 | 371 | 35 | 21 | 36 | N/A |
12/31/2018 | 368 | 36 | 24 | 38 | N/A |
9/30/2018 | 360 | 36 | 25 | 38 | N/A |
6/30/2018 | 352 | 36 | 27 | 39 | N/A |
3/31/2018 | 352 | 36 | N/A | 40 | N/A |
12/31/2017 | 352 | 35 | N/A | 41 | N/A |
9/30/2017 | 354 | 32 | N/A | 41 | N/A |
6/30/2017 | 356 | 29 | N/A | 40 | N/A |
3/31/2017 | 353 | 28 | N/A | 42 | N/A |
12/31/2016 | 350 | 28 | N/A | 43 | N/A |
9/30/2016 | 349 | 27 | N/A | 46 | N/A |
6/30/2016 | 348 | 25 | N/A | 49 | N/A |
3/31/2016 | 345 | 25 | N/A | 44 | N/A |
12/31/2015 | 343 | 24 | N/A | 39 | N/A |
9/30/2015 | 338 | 26 | N/A | N/A | N/A |
6/30/2015 | 333 | 28 | N/A | 38 | N/A |
3/31/2015 | 324 | 27 | N/A | 40 | N/A |
12/31/2014 | 315 | 26 | N/A | 41 | N/A |
9/30/2014 | 309 | 25 | N/A | N/A | N/A |
6/30/2014 | 304 | 24 | N/A | 32 | N/A |
3/31/2014 | 302 | 24 | N/A | 30 | N/A |
12/31/2013 | 300 | 24 | N/A | 28 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: VETODas prognostizierte Gewinnwachstum (8.9% pro Jahr) liegt über der Sparquote (1.4%).
Ertrag vs. Markt: VETODie Erträge des Unternehmens (8.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (12.5% pro Jahr).
Hohe Wachstumserträge: VETODie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: VETODie Einnahmen des Unternehmens (3.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.6% pro Jahr).
Hohe Wachstumseinnahmen: VETODie Einnahmen des Unternehmens (3.8% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: VETODie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.2%).